[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@trialradar Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1657931662079172609.png) @trialradar Clinical Trial Radar

Clinical Trial Radar posts on X about radar, $jazz, breast cancer, $ocgn the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1657931662079172609/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1657931662079172609/c:line/m:interactions.svg)

- X Week XXXXX +334%
- X Month XXXXX +159%
- X Months XXXXXX +466%
- X Year XXXXXX +14,625%

### Mentions: X [#](/creator/twitter::1657931662079172609/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1657931662079172609/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::1657931662079172609/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1657931662079172609/c:line/m:followers.svg)

- X Week XXX +13%
- X Month XXX +20%
- X Months XXX +417%

### CreatorRank: undefined [#](/creator/twitter::1657931662079172609/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1657931662079172609/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1657931662079172609/influence)
---

**Social topic influence**
[radar](/topic/radar) #319, [$jazz](/topic/$jazz), [breast cancer](/topic/breast-cancer), [$ocgn](/topic/$ocgn), [liver](/topic/liver), [$bivi](/topic/$bivi)

**Top assets mentioned**
[Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz)
### Top Social Posts [#](/creator/twitter::1657931662079172609/posts)
---
Top posts by engagements in the last XX hours

"$JAZZ Phase III trial is important as it tests zanidatamab + chemo for metastatic HER2-positive breast cancer after or intolerance to T-DXd aiming to fill a major post-T-DXd treatment gap. @JazzPharma"  
[X Link](https://x.com/trialradar/status/1978851704842981624) [@trialradar](/creator/x/trialradar) 2025-10-16T15:53Z XXX followers, XX engagements


"The $OCGN GARDian3 study is a Phase II/III pivotal trial evaluating OCU410ST a gene therapy for Stargardt disease (STGD). This rare inherited eye disorder causes progressive vision loss from fatty deposits in the retina"  
[X Link](https://x.com/trialradar/status/1978239855969599772) [@trialradar](/creator/x/trialradar) 2025-10-14T23:21Z XXX followers, XXX engagements


"Clinical Trial NCT07052253 tests Akesos AK104 + AK112 with TT-00420 (tinengotinib) in advanced Hepatocellular Carcinoma the most common liver cancer. 🧐 See this and all Akeso trials: 🔗"  
[X Link](https://x.com/trialradar/status/1955041403937214740) [@trialradar](/creator/x/trialradar) 2025-08-11T22:59Z XXX followers, XXX engagements


"$BIVI Enrollment is open for the Phase X ADDRESS-LC trial testing NE3107 in adults with Long COVID. This anti-inflammatory crosses the blood-brain barrier and was previously studied in Alzheimers and Parkinsons. The study evaluates if NE3107 can improve persistent brain fog and fatigue. @BioVie_Pharma 🔗"  
[X Link](https://x.com/trialradar/status/1978891872178442562) [@trialradar](/creator/x/trialradar) 2025-10-16T18:32Z XXX followers, XXX engagements